Jim Simons Cara Therapeutics, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,108,931 shares of CARA stock, worth $332,679. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,108,931

Previous 1,065,750 4.05%

Holding current value

$332,679

Previous $277,000 23.83%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.26 - $0.38 $11,227 - $16,408	43,181 Added 4.05%	1,108,931 $343,000
Q2 2024 Aug 09, 2024	SELL	$0.24 - $0.92 $64,014 - $245,389	-266,728 Reduced 20.02%	1,065,750 $277,000
Q1 2024 May 13, 2024	BUY	$0.52 - $1.05 $330,432 - $667,220	635,448 Added 91.17%	1,332,478 $1.21 Million
Q4 2023 Feb 13, 2024	BUY	$0.6 - $1.65 $231,078 - $635,464	385,130 Added 123.48%	697,030 $518,000
Q3 2023 Nov 14, 2023	SELL	$1.67 - $3.33 $203,990 - $406,759	-122,150 Reduced 28.14%	311,900 $524,000
Q2 2023 Aug 11, 2023	BUY	$2.83 - $4.94 $1.13 Million - $1.97 Million	398,482 Added 1120.34%	434,050 $1.23 Million
Q1 2023 May 12, 2023	BUY	$4.89 - $12.27 $173,927 - $436,419	35,568 New	35,568 $175,000
Q2 2022 Aug 12, 2022	SELL	$7.45 - $13.84 $1.19 Million - $2.2 Million	-159,150 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$9.94 - $12.65 $2.01 Million - $2.55 Million	-201,800 Reduced 55.91%	159,150 $1.93 Million
Q4 2021 Feb 11, 2022	BUY	$11.99 - $18.14 $4.33 Million - $6.55 Million	360,950 New	360,950 $4.4 Million
Q3 2021 Nov 12, 2021	SELL	$11.55 - $16.06 $1.81 Million - $2.51 Million	-156,460 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$12.38 - $29.19 $1.3 Million - $3.06 Million	-104,990 Reduced 40.16%	156,460 $2.23 Million
Q1 2021 May 13, 2021	SELL	$15.07 - $21.71 $260,168 - $374,801	-17,264 Reduced 6.19%	261,450 $5.68 Million
Q4 2020 Feb 10, 2021	SELL	$12.72 - $16.16 $257,580 - $327,240	-20,250 Reduced 6.77%	278,714 $4.22 Million
Q3 2020 Nov 13, 2020	BUY	$12.34 - $17.92 $2.59 Million - $3.77 Million	210,114 Added 236.48%	298,964 $3.8 Million
Q2 2020 Aug 13, 2020	BUY	$12.39 - $17.33 $1.1 Million - $1.54 Million	88,850 New	88,850 $1.52 Million
Q1 2019 May 14, 2019	SELL	$14.41 - $19.64 $5.95 Million - $8.11 Million	-413,150 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$12.45 - $23.47 $5.14 Million - $9.7 Million	413,150 New	413,150 $5.37 Million

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.1M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account